Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1996-05-02
1999-11-16
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514174, 552276, A01N 4500
Patent
active
059858621
ABSTRACT:
The present invention discloses novel pharmaceutical compositions having steroid nitrate ester(ONO.sub.2) derivatives, and to their use treating undesired smooth muscle contractions and inflammatory diseases.
REFERENCES:
patent: 3639434 (1972-02-01), Oxley et al.
patent: 3839369 (1974-10-01), Hofmeister et al.
Translation of DE 2,222,491, Nov. 16, 1972.
Moncada et al, Biochem.Pharm. 38:1709-1715 (1989).
Moncada et al., Pharm.Review 43:109-147 (1991).
Moncada et al., Jour.Cardio.Pharm. 17:(1991), 525-527.
Persson et al., Eur.Jour.Pharm. 249 R7-R8 (1993).
Alspaugh & Granger, Infection and Immunity, 59:2291-2296 (1991).
Wallace et al., Eur.Jour.Pharm. 257:249-255 (1994).
MacIntyre et al., Proc.Nat.Acad.Sci. USA 88 2936-2940 (1991).
Pipili-Synetos et al, Britis Journal of Pharmacology 116, 1829-1834 (1995).
Currie Mark G.
Tjoeng Foe S.
Zupec Mark E.
Bennett Dennis A.
G.D. Searle & Co.
Jones Dwayne C.
Scrivner Alan L.
LandOfFree
Pharmaceutical compositions having steroid nitrate ester derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions having steroid nitrate ester derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions having steroid nitrate ester derivat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1324903